Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00422279 · ClinicalTrials.gov registry record · NA
A Study of Dental Implants Coated With Bone Morphogenetic Protein
A NA study of Alveolar Ridge Abnormality, sponsored by Nobel Biocare.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT00422279 is a NA study of Alveolar Ridge Abnormality that has completed, run by Nobel Biocare. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00422279, a NA study of Alveolar Ridge Abnormality, has completed, sponsored by Nobel Biocare.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate implant stability and stimulate clinically relevant horizontal and vertical new bone formation around Nobel Biocare's Bone Inductive Implant.
Conditions Studied
Interventions
- DEVICE Nobel Replace Tapered Groovy
Study Locations (1)
Georgia
- Medical College of Georgia - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00422279
The ClinicalTrials.gov registry entry for NCT00422279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nobel Biocare, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alveolar Ridge Abnormality appearing as the primary indexed condition, and to 1 intervention - of which Nobel Replace Tapered Groovy is the first listed.
NCT00422279 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00422279 about?
NCT00422279 is a clinical study titled "A Study of Dental Implants Coated With Bone Morphogenetic Protein". The purpose of the study is to evaluate implant stability and stimulate clinically relevant horizontal and vertical new bone formation around Nobel Biocare's Bone Inductive Implant.
What is the current status of trial NCT00422279?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2006-11. Estimated completion is 2009-11.
What conditions does trial NCT00422279 study?
This clinical trial studies the following conditions: Alveolar Ridge Abnormality.
What interventions are being tested in trial NCT00422279?
The interventions under investigation include: Nobel Replace Tapered Groovy (DEVICE).
Who is sponsoring clinical trial NCT00422279?
This trial is sponsored by Nobel Biocare, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00422279 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.